956-90-1 Usage
Uses
Used in Pharmaceutical Industry:
Phencyclidine hydrochloride is used as a controlled substance for its depressant effects on the central nervous system. It was historically employed as an anesthetic due to its ability to induce a state of dissociative anesthesia, characterized by a lack of sensation and perception while maintaining muscle tone and reflexes.
Used in Research and Forensic Applications:
PCP is utilized in research settings to study the effects of dissociative drugs on the central nervous system and to develop potential treatments for neurological disorders. Additionally, it is used in forensic applications for the detection and analysis of the drug in cases of substance abuse or criminal activity.
Biological Activity
Non-competitive NMDA receptor antagonist and sigma receptor agonist. Psychostimulant; induces rotational behavior, head-weaving and cognitive dysfunction in rats.
Biochem/physiol Actions
σ opioid receptor agonist and psychostimulant; inhibits NMDA glutamate receptor activation by binding to an allosteric site within the ion channel.
Safety Profile
Poison by ingestion,subcutaneous, intravenous, and intraperitoneal routes.Human systemic effects by ingestion and intravenousroutes: distorted perceptions, euphoria, excitement,hallucinations, and paresthesia. An experimental teratogen.Other experime
Check Digit Verification of cas no
The CAS Registry Mumber 956-90-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 9,5 and 6 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 956-90:
(5*9)+(4*5)+(3*6)+(2*9)+(1*0)=101
101 % 10 = 1
So 956-90-1 is a valid CAS Registry Number.
InChI:InChI=1/C17H25N.ClH/c1-4-10-16(11-5-1)17(12-6-2-7-13-17)18-14-8-3-9-15-18;/h1,4-5,10-11H,2-3,6-9,12-15H2;1H
956-90-1Relevant articles and documents
New morpholine analogues of phencyclidine: Chemical synthesis and pain perception in rats
Ahmadi, Abbas,Khalili, Mohsen,Hajikhani, Ramin,Naserbakht, Moslem
, p. 227 - 233 (2013/01/09)
Phencyclidine (PCP, I) and most its derivatives have demonstrated some pharmacological effects. Accordingly, in this study, the new methoxy (III) and hydroxy-methyl (IV) morpholine PCP derivatives were synthesized. The acute and chronic pain activities of these drugs (III, IV) were investigated by tail immersion and formalin tests on rats and the results were compared with those in PCP, PCM (PCP-morpholine, II), and methyl-PCM (V). Findings indicated that III (6 mg/kg, i.p.) generates more analgesic effects in tail immersion test in comparison with I and II in 20, 40, 45 and 55 min post-injection. These effects were observed in 10, 20, 40, 45 and 50 min after the application of IV (at the same dosage). This analgesic effect was markedly seen in 20, 40, 45 and 50 min after compound IVs application in comparison with the drugs (I-V). In formalin test analysis, the acute chemical pain (Phase I) could not be affected by any drugs (I-V) while chronic formalin pain would be diminished by these new synthesized drugs (III and IV), especially in late Phase II, compared to I and II at the dosage of 6 mg/kg. It is, therefore, concluded that these new synthesized PCP derivates including methoxy-PCM (III) and hydroxy-methyl-PCM (IV) could substantially and respectively diminish acute thermal and chronic chemical pains.